Chase D M, Basu T, Saffari B, Ries S, Berman M L
Department of Obstetrics & Gynecology, University of California-Irvine Medical Center, 101 The City Drive South, Orange, CA 92868, USA.
Int J Gynecol Cancer. 2006 May-Jun;16(3):1465-9. doi: 10.1111/j.1525-1438.2006.00608.x.
Malignant eccrine spiradenoma is a rare skin tumor of sweat gland origin. We present the first reported case of this tumor in the female genitalia. Due to the rarity of this tumor, there has yet to be an established standard of care. The present case is that of a 41-year-old woman with malignant eccrine spiradenoma of the periclitoral region. She had an 18-month history of a recurrent, painful mass adjacent to the clitoris. Her diagnosis was made after excision of the cystic tumor. The patient then underwent a partial radical vulvectomy with bilateral sentinel lymph node sampling. As malignant eccrine spiradenoma is a rare tumor, no standard care exists for treatment and postoperative management. Based on our review of the literature, wide local excision appears to be the preferred initial treatment. Furthermore, adjuvant chemotherapy and/or radiation does not seem to improve survival in patients with advanced or recurrent cancer. Although lymph node sampling and/or lymphadenectomy is frequently reported in the treatment of this tumor, hematogenous metastasis can also occur. Therefore, these patients require close postoperative follow-up for recurrent disease.
恶性小汗腺螺旋腺瘤是一种罕见的起源于汗腺的皮肤肿瘤。我们报告了首例该肿瘤发生于女性生殖器的病例。由于这种肿瘤罕见,尚未有既定的治疗标准。本病例为一名41岁女性,患有阴蒂周围区域的恶性小汗腺螺旋腺瘤。她有一个位于阴蒂旁反复出现的疼痛性肿块,病史长达18个月。在切除囊性肿瘤后做出了诊断。患者随后接受了部分根治性外阴切除术及双侧前哨淋巴结取样。由于恶性小汗腺螺旋腺瘤是一种罕见肿瘤,对于其治疗和术后管理尚无标准的治疗方案。根据我们对文献的回顾,广泛局部切除似乎是首选的初始治疗方法。此外,辅助化疗和/或放疗似乎并不能提高晚期或复发性癌症患者的生存率。尽管在该肿瘤的治疗中经常报道进行淋巴结取样和/或淋巴结清扫术,但也可能发生血行转移。因此,这些患者术后需要密切随访以观察疾病复发情况。